Skip to main content
S 2754 109th Congress Senate Health Administrative procedure Congress Congressional reporting requirements Cytology Department of Health and Human Services Government Operations and Politics Human embryology Law Medical research Science, Technology, Communications

Alternative Pluripotent Stem Cell Therapies Enhancement Act

Introduced: May 5, 2006 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 19 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 18, 2006
Considered as unfinished business. (consideration: CR H5360)
Jul 18, 2006
Failed of passage/not agreed to in House: On motion to suspend the rules and pass the bill Failed by the Yeas and Nays: (2/3 required): 273 - 154 (Roll no. 380).(text: CR H5352-5353)
Jul 18, 2006
Rules Committee Resolution H. Res. 924 Reported to House. Rule provides for consideration of S. 2754 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit. Measure will be considered read. Bill is closed to amendments.
Jul 18, 2006
Motion to reconsider laid on the table Agreed to without objection.
Jul 18, 2006
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jul 18, 2006
DEBATE - The House proceeded with forty minutes of debate on S. 2754.
Jul 18, 2006
Considered under suspension of the rules. (consideration: CR H5352-5359)
Jul 18, 2006
Mr. Barton (TX) moved to suspend the rules and pass the bill.
Jul 18, 2006
Message on Senate action sent to the House.
Jul 18, 2006
Held at the desk.
Jul 18, 2006
Received in the House.
Jul 18, 2006
Passed Senate without amendment by Yea-Nay Vote. 100 - 0. Record Vote Number: 205. (text: CR S7692)
Jul 18, 2006
Passed/agreed to in Senate: Passed Senate without amendment by Yea-Nay Vote. 100 - 0. Record Vote Number: 205.(text: CR S7692)
Jul 18, 2006
Considered by Senate. (consideration: CR S7654-7692)
Jul 17, 2006
Measure laid before Senate by unanimous consent. (consideration: CR S7569-7623)
Jul 17, 2006
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Jun 27, 2006
Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies. Hearings held. With printed Hearing: S.Hrg. 109-815.
May 5, 2006
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 5, 2006
Introduced in Senate
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Jul 18, 2006 House · vote #380 On Motion to Suspend the Rules and Pass Failed 273–154 See who voted →
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Alternative Pluripotent Stem Cell Therapies Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services to develop techniques for the isolation, derivation, production, or testing of stem cells that are capable of producing all or almost all of the cell types of the developing body and may result in improved understanding of treatments for diseases and other adverse health conditions, but that are not derived from a human embryo.

Requires the Secretary to: (1) provide guidance concerning the next steps required for additional research; (2) prioritize research with the greatest potential for near-term clinical benefit; and (3) take into account techniques outlined by the President's Council on Bioethics and any other appropriate techniques and research.

What's happening now July 18, 2006

Rules Committee Resolution H. Res. 924 Reported to House. Rule provides for consideration of S. 2754 with 1 hour of general debate. Previous question shall be considered as ordered without intervening motions except motion to recommit. Measure will be considered read. Bill is closed to amendments.

 Related & companion bills 2
  • HR 5526 Identical bill Alternative Pluripotent Stem Cell Therapies Enhancement Act
  • HRES 924 Procedurally related Providing for consideration of the bill (S. 2754) to derive human pluripotent stem cell lines using techniques that do …
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 1
All 1 Republican 1
R
Collins, Susan M.
Maine · Jul 11, 2006
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2754: Alternative Pluripotent Stem Cell Therapies Enhancement Act. 109th Congress. Open America. https://openamerica.io/bill/109-S-2754/
MLA
"S. 2754: Alternative Pluripotent Stem Cell Therapies Enhancement Act." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-S-2754/.
Bluebook (legal)
S. 2754, 109th Cong. (2026), https://openamerica.io/bill/109-S-2754/.
Markdown link
[S. 2754: Alternative Pluripotent Stem Cell Therapies Enhancement Act](https://openamerica.io/bill/109-S-2754/)
Report a problem